Evidence-Based Evaluation and Treatment of Acute Rhinosinusitis in Adults (Infectious Disease CME, Pharmacology CME, and Risk Management CME) | Points & Pearls
Click to check your cart0
Evidence-Based Urgent Care

Points & Pearls • Free Excerpt

November Evidence-Based Urgent Care issue cover

November 2026 • Volume 5 • Issue 11

Evidence-Based Evaluation and Treatment of Acute Rhinosinusitis in Adults

Infectious Disease CME • Pharmacology CME • Risk Management CME

Review key clinical takeaways from the accompanying Evidence-Based Urgent Care issue.

Points & Pearls Excerpt

  • Most acute rhinosinusitis is viral; <2% of cases progress to acute bacterial rhinosinusitis (ABRS).
  • Diagnosis of acute rhinosinusitis is primarily clinical and should focus on symptom duration, progression, and the presence of nasal obstruction, purulent drainage, and facial pain or pressure.
  • Routine laboratory testing and imaging are not indicated for uncomplicated rhinosinusitis; advanced imaging should be reserved for suspected complications or high-risk presentations.
  • Symptomatic care is appropriate for most patients, and systemic corticosteroids are not routinely recommended because of limited benefit and potential adverse effects.

Continue Reading the Companion Article

Already have access through your EB Medicine subscription?
Log in to continue to the companion article.

To Read The Companion Article:
To Read The Companion Article:
To Read The Companion Article:
Content you might be interested in
Get A Sample Issue Of Emergency Medicine Practice
Enter your email to get your copy today! Plus receive updates on EB Medicine every month.
Verification Word:
Enter Verification Word: